metylperon has been researched along with haloperidol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Arlock, P; Gullberg, B; Olsson, SR | 1 |
| Elgen, K; Fuglum, E; Nygaard, HA | 1 |
| Christensson, E; Egbe, P; Engel, J; Gustafsson, B | 1 |
| Gunne, LM; Johansson, P | 1 |
| Gudelsky, GA; Meltzer, HY; Nash, JF | 1 |
| Molander, L | 1 |
| Evans, DL; Figur, LM; Lahti, RA; Stratman, NC | 1 |
| Dai, J; Ichikawa, J; Li, Z; Meltzer, HY | 1 |
| Baker, LE; Meltzer, HY; Prus, AJ | 1 |
| Bischoff, A | 1 |
| Chowdhury, S; Kumar, S | 1 |
| Doblhammer, G; Eriksdotter, M; Garcia-Ptacek, S; Haenisch, B; Johnell, K; Nerius, M | 1 |
1 review(s) available for metylperon and haloperidol
| Article | Year |
|---|---|
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blind Method; Female; Haloperidol; Homes for the Aged; Humans; Male; Meta-Analysis as Topic; Methotrimeprazine; Norway; Nursing Homes; Severity of Illness Index; Tranquilizing Agents | 1992 |
2 trial(s) available for metylperon and haloperidol
| Article | Year |
|---|---|
Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway.
Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clopenthixol; Double-Blind Method; Female; Haloperidol; Homes for the Aged; Humans; Male; Meta-Analysis as Topic; Methotrimeprazine; Norway; Nursing Homes; Severity of Illness Index; Tranquilizing Agents | 1992 |
Effect of melperone, chlorpromazine, haloperidol, and diazepam on experimental anxiety in normal subjects.
Topics: Acoustic Stimulation; Adult; Anti-Anxiety Agents; Butyrophenones; Chlorpromazine; Diazepam; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Haloperidol; Humans; Male; Reinforcement, Psychology | 1982 |
12 other study(ies) available for metylperon and haloperidol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.
Topics: Action Potentials; Animals; Antipsychotic Agents; Butyrophenones; Chlorpromazine; Guinea Pigs; Haloperidol; Heart; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Papillary Muscles; Piperidines; Refractory Period, Electrophysiological; Thioridazine | 1978 |
Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine.
Topics: alpha-Methyltyrosine; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Butyrophenones; Chlorpromazine; Clozapine; Conditioning, Operant; Drug Synergism; Female; Food; Haloperidol; Male; Methyltyrosines; Piperazines; Psychotropic Drugs; Rats; Rats, Inbred Strains; Reinforcement Schedule | 1990 |
Chronic melperone administration does not enhance oral movements in rats.
Topics: Animals; Antipsychotic Agents; Butyrophenones; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Mastication; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1989 |
Antagonism of serotonin receptor mediated neuroendocrine and temperature responses by atypical neuroleptics in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Body Temperature; Butyrophenones; Chlorpromazine; Clozapine; Corticosterone; Haloperidol; Male; Neurosecretory Systems; Pyrazines; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Tetrahydronaphthalenes | 1988 |
Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
Topics: Animals; Apomorphine; Butyrophenones; Cell Line; Chlorpromazine; Clozapine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Trifluoperazine | 1993 |
Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Butyrophenones; Clozapine; Dibenzothiazepines; Dopamine; Haloperidol; Isoxazoles; Male; Microdialysis; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1 | 2002 |
Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Butyrophenones; Clozapine; Discrimination, Psychological; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fluorobenzenes; Generalization, Stimulus; Haloperidol; Male; Muscarinic Antagonists; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Trihexyphenidyl | 2004 |
[Acutely confused old man].
Topics: Acute Disease; Aged; Antipsychotic Agents; Benzodiazepines; Butyrophenones; Confusion; Haloperidol; Hospitalization; Humans; Male; Psychomotor Disorders | 2010 |
In silico repurposing of antipsychotic drugs for Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid Precursor Protein Secretases; Antipsychotic Agents; Aspartic Acid Endopeptidases; Butyrophenones; Butyrylcholinesterase; Drug Repositioning; Glucosides; Haloperidol; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Norisoprenoids; Pimozide; Psychotropic Drugs; Receptors, N-Methyl-D-Aspartate | 2017 |
The Impact of Antipsychotic Drugs on Long-term Care, Nursing Home Admission, and Death in Dementia Patients.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Butyrophenones; Cohort Studies; Dementia; Female; Germany; Haloperidol; Homes for the Aged; Humans; Institutionalization; Long-Term Care; Male; Middle Aged; Nursing Homes; Proportional Hazards Models; Quetiapine Fumarate; Risk Factors; Risperidone | 2018 |